Literature DB >> 2352926

Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden.

S Hirosawa1, J B Fahner, J P Salier, C T Wu, E W Lovrien, K Kurachi.   

Abstract

Hemophilia B Leyden is characterized by unusual developmental regulation of factor IX synthesis in affected individuals. One family affected with the hemophilia B Leyden phenotype was found to have a specific single-base mutation (G----A) at nucleotide -6 of the factor IX gene. The mutation site was found in a small region of the 5'-untranslated sequence designated the Leyden-specific region (LS region). This region, approximately 40 base pairs in length, contains the unique mutation sites of all the known factor IX Leyden genes (five families) analyzed to date. This fact strongly suggests that the LS region is directly or indirectly involved in the developmental regulation of factor IX biosynthesis. Base changes at nucleotide -20 as well as at nucleotide -6 and deletions of the 3' half of the LS region reduced expression activity of the factor IX gene to approximately 15-31% that of the normal control, as assessed in a cultured cell (HepG2) expression system. The LS region binds at least two proteins. Androgen significantly increased the transcriptional activities of both mutant and normal factor IX genes in a concentration-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2352926      PMCID: PMC54126          DOI: 10.1073/pnas.87.12.4421

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

2.  'Normal' haemostasis parameters: a study in a well-defined inborn population of preterm infants.

Authors:  D W Beverley; M J Inwood; G W Chance; M Schaus; B O'Keefe
Journal:  Early Hum Dev       Date:  1984-04       Impact factor: 2.079

3.  Hemophilia B Leyden: a sex-linked hereditary disorder that improves after puberty.

Authors:  E Briët; R M Bertina; N H van Tilburg; J J Veltkamp
Journal:  N Engl J Med       Date:  1982-04-01       Impact factor: 91.245

4.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

5.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

6.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease.

Authors:  H R Gralnick; M E Rick
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

8.  Effect of danazol on coagulation parameters and bleeding in hemophilia.

Authors:  H S Garewal; J J Corrigan; B G Durie; M A Jeter; M L Damiano
Journal:  JAMA       Date:  1985-02-22       Impact factor: 56.272

9.  Coagulation factors in the premature infant born after about 32 weeks of gestation.

Authors:  J P Terwiel; J J Veltkamp; R M Bertina; I K van der Linden; N H van Tilburg
Journal:  Biol Neonate       Date:  1985

10.  Benefits of danazol treatment in patients with hemophilia A (classic hemophilia).

Authors:  H R Gralnick; P Maisonneuve; Y Sultan; M E Rick
Journal:  JAMA       Date:  1985-02-22       Impact factor: 56.272

View more
  13 in total

1.  Haemophilia B: database of point mutations and short additions and deletions--second edition.

Authors:  F Giannelli; P M Green; K A High; S Sommer; D P Lillicrap; M Ludwig; K Olek; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

2.  Haemophilia B: database of point mutations and short additions and deletions--third edition, 1992.

Authors:  F Giannelli; P M Green; K A High; S Sommer; D P Lillicrap; M Ludwig; K Olek; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

3.  An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B Leyden.

Authors:  Sumiko Kurachi; Jeffrey S Huo; Afshin Ameri; Kezhong Zhang; Akiyasu C Yoshizawa; Kotoku Kurachi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

4.  Haemophilia B: database of point mutations and short additions and deletions--fourth edition, 1993.

Authors:  F Giannelli; P M Green; K A High; S Sommer; M C Poon; M Ludwig; R Schwaab; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1993-07-01       Impact factor: 16.971

5.  The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene.

Authors:  C D Bottema; R P Ketterling; E Vielhaber; H S Yoon; B Gostout; D P Jacobson; A Shapiro; S S Sommer
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

6.  Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor V111 gene.

Authors:  L K McGlynn; C R Mueller; M Begbie; C R Notley; D Lillicrap
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

7.  CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series.

Authors:  S H Chen; M Zhang; E W Lovrien; C R Scott; A R Thompson
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

8.  Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.

Authors:  D Vidaud; M Tartary; J M Costa; B R Bahnak; S Gispert-Sanchez; E Fressinaud; C Gazengel; D Meyer; M Goossens; J M Lavergne
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

9.  Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994.

Authors:  F Giannelli; P M Green; S S Sommer; D P Lillicrap; M Ludwig; R Schwaab; P H Reitsma; M Goossens; A Yoshioka; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

Review 10.  Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors.

Authors:  Herbert H Watzke
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.